196 related articles for article (PubMed ID: 32241263)
21. Functional analysis of a large set of BRCA2 exon 7 variants highlights the predictive value of hexamer scores in detecting alterations of exonic splicing regulatory elements.
Di Giacomo D; Gaildrat P; Abuli A; Abdat J; Frébourg T; Tosi M; Martins A
Hum Mutat; 2013 Nov; 34(11):1547-57. PubMed ID: 23983145
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide analysis of noncoding regulatory mutations in cancer.
Weinhold N; Jacobsen A; Schultz N; Sander C; Lee W
Nat Genet; 2014 Nov; 46(11):1160-5. PubMed ID: 25261935
[TBL] [Abstract][Full Text] [Related]
23. Splicing mutations in human genetic disorders: examples, detection, and confirmation.
Anna A; Monika G
J Appl Genet; 2018 Aug; 59(3):253-268. PubMed ID: 29680930
[TBL] [Abstract][Full Text] [Related]
24. Computational Identification of Tissue-Specific Splicing Regulatory Elements in Human Genes from RNA-Seq Data.
Badr E; ElHefnawi M; Heath LS
PLoS One; 2016; 11(11):e0166978. PubMed ID: 27861625
[TBL] [Abstract][Full Text] [Related]
25. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
[TBL] [Abstract][Full Text] [Related]
26. OncoBase: a platform for decoding regulatory somatic mutations in human cancers.
Li X; Shi L; Wang Y; Zhong J; Zhao X; Teng H; Shi X; Yang H; Ruan S; Li M; Sun ZS; Zhan Q; Mao F
Nucleic Acids Res; 2019 Jan; 47(D1):D1044-D1055. PubMed ID: 30445567
[TBL] [Abstract][Full Text] [Related]
27. Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas.
Tanimoto K; Muramatsu T; Inazawa J
Cancer Med; 2019 Dec; 8(17):7372-7384. PubMed ID: 31631560
[TBL] [Abstract][Full Text] [Related]
28. TP53 mutations, expression and interaction networks in human cancers.
Wang X; Sun Q
Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
[TBL] [Abstract][Full Text] [Related]
29. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Han W; Huang B; Zhao XY; Shen GL
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
[TBL] [Abstract][Full Text] [Related]
30. A synonymous mutation in SPINK5 exon 11 causes Netherton syndrome by altering exonic splicing regulatory elements.
Fortugno P; Grosso F; Zambruno G; Pastore S; Faletra F; Castiglia D
J Hum Genet; 2012 May; 57(5):311-5. PubMed ID: 22377713
[TBL] [Abstract][Full Text] [Related]
31. Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome.
Cheng F; Jia P; Wang Q; Lin CC; Li WH; Zhao Z
Mol Biol Evol; 2014 Aug; 31(8):2156-69. PubMed ID: 24881052
[TBL] [Abstract][Full Text] [Related]
32. Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease.
Claverie-Martin F; Gonzalez-Paredes FJ; Ramos-Trujillo E
RNA Biol; 2015; 12(4):369-74. PubMed ID: 25757501
[TBL] [Abstract][Full Text] [Related]
33. Cancer subtype identification using somatic mutation data.
Kuijjer ML; Paulson JN; Salzman P; Ding W; Quackenbush J
Br J Cancer; 2018 May; 118(11):1492-1501. PubMed ID: 29765148
[TBL] [Abstract][Full Text] [Related]
34. An analysis of mutational signatures of synonymous mutations across 15 cancer types.
Bin Y; Wang X; Zhao L; Wen P; Xia J
BMC Med Genet; 2019 Dec; 20(Suppl 2):190. PubMed ID: 31815613
[TBL] [Abstract][Full Text] [Related]
35. Cancer somatic mutations cluster in a subset of regulatory sites predicted from the ENCODE data.
Shar NA; Vijayabaskar MS; Westhead DR
Mol Cancer; 2016 Nov; 15(1):76. PubMed ID: 27887606
[TBL] [Abstract][Full Text] [Related]
36. Splicing dysregulation contributes to the pathogenicity of several F9 exonic point variants.
Katneni UK; Liss A; Holcomb D; Katagiri NH; Hunt R; Bar H; Ismail A; Komar AA; Kimchi-Sarfaty C
Mol Genet Genomic Med; 2019 Aug; 7(8):e840. PubMed ID: 31257730
[TBL] [Abstract][Full Text] [Related]
37. Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.
Nielsen KB; Sørensen S; Cartegni L; Corydon TJ; Doktor TK; Schroeder LD; Reinert LS; Elpeleg O; Krainer AR; Gregersen N; Kjems J; Andresen BS
Am J Hum Genet; 2007 Mar; 80(3):416-32. PubMed ID: 17273963
[TBL] [Abstract][Full Text] [Related]
38. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.
Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR
Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911
[TBL] [Abstract][Full Text] [Related]
39. Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers.
Lamolle G; Marin M; Alvarez-Valin F
Mutat Res; 2006 Aug; 600(1-2):102-12. PubMed ID: 16650445
[TBL] [Abstract][Full Text] [Related]
40. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.
Balakrishnan A; Bleeker FE; Lamba S; Rodolfo M; Daniotti M; Scarpa A; van Tilborg AA; Leenstra S; Zanon C; Bardelli A
Cancer Res; 2007 Apr; 67(8):3545-50. PubMed ID: 17440062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
